services in order to ensure that the organisation is providing a safe clinical area for our patients and staff.
2.1.2 Elective Recovery, Innovation, & Community Services Elective Recovery
i)
North Central London (NCL) Integrated Care System (ICS)
Referral Validation & Triage
From April 2022 until March 2023, NNPC was commissioned to engage with, review, risk-stratify and prioritise patients who have been ‘referred but not seen’ as part of the Elective Recovery Program within the North Central London (NCL) ICS. PSL and the Eclipse Live system were included as part of the approach. The intended outcomes were to reduce the numbers waiting to be seen and to enable hidden clinical risks to be identified by bringing together patient derived feedback with current clinical insight. NCL includes the Royal Free London Hospital, University College London, and Whittington Health. ENT was selected by NCL as the initial specialty to work with, followed by Dermatology and Ophthalmology. Patients were engaged via an on-line questionnaire which was agreed with the clinical team at the Royal Free Hospital (including risk assessment scores). Patients were asked to complete the questionnaire which provided insight into their view of their health status, and this was aligned with their current medical information to risk assess and prioritise the patient. Patients were supported in their use of the on-line system (Eclipse) by nursing and administrative staff where necessary, plus escalation to doctors for review. The system was monitored so that patients who did not complete the questionnaire could be followed up with phone calls, which were made during the day, evenings, and weekends.
The main points and outcomes from the service were as follows:
687 ENT patients were reviewed:
• 27% of patients were removed from th e waiting list in line with the Royal Free Hospital’s access policy. • 7% patients were identified as meeting the Core20 (high deprivation) criteria for health inequalities. • 8% patients were identified as higher priority (>50%) using the locally defined risk calculator.
838 Dermatology patients were reviewed:
• 30% of patients were removed from the waiting list in line with the access policy. • A further 228 patients have been selected by the Royal Free for the process.
926 Ophthalmology patients were reviewed:
NNPC Quality Account 2022/23
7 | Pa g e
Made with FlippingBook Digital Proposal Creator